GlassScriptPhysician profile
Philip G Padgett
NPI 1063516151
$7,725.68
in general payments reported to CMS, 2019-2025
39 companies · $961 in 2025
The $961 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $888 · 2021: $1,615 · 2022: $1,163 · 2023: $1,443 · 2024: $1,273 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,677.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,175.26 | 2019-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $1,175.09 | 2021-2025 | |
| Pfizer INC. | $658.35 | 2019-2025 | |
| Amarin Pharma, INC. | $556.15 | 2020-2022 | |
| Lilly USA, LLC | $497.95 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $369.18 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Kowa Pharmaceuticals America, INC. | $272.40 | 2019-2023 | Seglentis, Livalo |
| Abbott Laboratories | $267.96 | 2021-2025 | Freestyle Libre 3 |
| Allergan, INC. | $213.13 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $212.99 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $196.48 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $195.83 | 2020-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Esperion Therapeutics, INC. | $188.20 | 2023-2025 | Nexletol |
| Corium, LLC | $168.15 | 2022-2025 | Azstarys |
| Exact Sciences Corporation | $153.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Padgett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.